<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Orthopediatrics Corp — News on 6ix</title>
<link>https://6ix.com/company/orthopediatrics-corp</link>
<description>Latest news and press releases for Orthopediatrics Corp on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Thu, 16 Apr 2026 20:05:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/orthopediatrics-corp" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo68358e2b78dffbe2df1011ab.webp</url>
<title>Orthopediatrics Corp</title>
<link>https://6ix.com/company/orthopediatrics-corp</link>
</image>
<item>
<title>OrthoPediatrics Corp. to Report First Quarter Financial Results on April 30, 2026</title>
<link>https://6ix.com/company/orthopediatrics-corp/news/orthopediatrics-corp-to-report-first-quarter-financial-results-on-april-30-2026</link>
<guid isPermaLink="true">https://6ix.com/company/orthopediatrics-corp/news/orthopediatrics-corp-to-report-first-quarter-financial-results-on-april-30-2026</guid>
<pubDate>Thu, 16 Apr 2026 20:05:00 GMT</pubDate>
<description>WARSAW, Ind., April 16, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its first quarter 2026 financial results on Thursday, April 30, 2026 after the market closes. OrthoPediatrics will host a conference call on Thursday, April 30, 2026 at 4:30 p.m. ET to discuss the results. Investors interested in listening</description>
</item>
<item>
<title>OrthoPediatrics to Participate in the 25th Annual Needham Virtual Healthcare Conference</title>
<link>https://6ix.com/company/orthopediatrics-corp/news/orthopediatrics-to-participate-in-the-25th-annual-needham-virtual-healthcare-conference</link>
<guid isPermaLink="true">https://6ix.com/company/orthopediatrics-corp/news/orthopediatrics-to-participate-in-the-25th-annual-needham-virtual-healthcare-conference</guid>
<pubDate>Tue, 31 Mar 2026 20:05:00 GMT</pubDate>
<description>WARSAW, Ind., March 31, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey, President & Chief Executive Officer, and Fred Hite, Chief Operating Officer, and Chief Financial Officer, are scheduled to participate in a fireside chat at the 25th Annual Needham Virtual Healthcare Conference. Event: 25th Annual Needham Virtual Healthcare Confe</description>
</item>
<item>
<title>OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2025 Financial Results</title>
<link>https://6ix.com/company/orthopediatrics-corp/news/orthopediatrics-corp-reports-fourth-quarter-and-full-year-2025-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/orthopediatrics-corp/news/orthopediatrics-corp-reports-fourth-quarter-and-full-year-2025-financial-results</guid>
<pubDate>Thu, 26 Feb 2026 21:05:00 GMT</pubDate>
<description>Record full year 2025 revenue of $236.3 million increased 15% compared to prior yearOperating Cash flow improvement of $22 million in full year 2025Generated $10 million of free cash flow in the fourth quarter, the first quarter of positive free cash flow in Company history WARSAW, Ind., Feb. 26, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its fin</description>
</item>
<item>
<title>OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026</title>
<link>https://6ix.com/company/orthopediatrics-corp/news/orthopediatrics-corp-report-fourth-quarter-210500916</link>
<guid isPermaLink="true">https://6ix.com/company/orthopediatrics-corp/news/orthopediatrics-corp-report-fourth-quarter-210500916</guid>
<pubDate>Thu, 12 Feb 2026 21:05:00 GMT</pubDate>
<description>WARSAW, Ind., Feb. 12, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its fourth quarter and full year 2025 financial results on Thursday, February 26, 2026 after the market closes. OrthoPediatrics will host a conference call on Thursday, February 26, 2026 at 4:30 p.m. ET to discuss the results. Investors inte</description>
</item>
<item>
<title>OrthoPediatrics Announces Expanded Enabling Technology Market Opportunity</title>
<link>https://6ix.com/company/orthopediatrics-corp/news/orthopediatrics-announces-expanded-enabling-technology-120500730</link>
<guid isPermaLink="true">https://6ix.com/company/orthopediatrics-corp/news/orthopediatrics-announces-expanded-enabling-technology-120500730</guid>
<pubDate>Tue, 03 Feb 2026 12:05:00 GMT</pubDate>
<description>OrthoPediatrics partner iotaMotion receives FDA clearance for use of its iotaSOFT® cochlear implant insertion system in patients four years and olderWARSAW, Ind., Feb. 03, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its partner, iotaMotion, has received FDA 510(k) clearance for expanded pediatric use of its iotaSOFT® Insertion System. The system i</description>
</item>
<item>
<title>OrthoPediatrics Corp. Achieves Record Preliminary Unaudited Revenue for Full Year 2025 and Issues 2026 Financial Guidance</title>
<link>https://6ix.com/company/orthopediatrics-corp/news/orthopediatrics-corp-achieves-record-preliminary-120500679</link>
<guid isPermaLink="true">https://6ix.com/company/orthopediatrics-corp/news/orthopediatrics-corp-achieves-record-preliminary-120500679</guid>
<pubDate>Mon, 12 Jan 2026 12:05:00 GMT</pubDate>
<description>Achieves all-time high full year 2025 Revenue of $236.1 million representing growth of 15% over prior yearInitiates guidance for record Adjusted EBITDA in 2026 WARSAW, Ind., Jan. 12, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced preliminary unaudited financial highlights for the fourth quarter and full year ended December 31, 2025, issued 2026 finan</description>
</item>
<item>
<title>OrthoPediatrics Corp. Expands Specialty Bracing Portfolio with Two New Product Launches</title>
<link>https://6ix.com/company/orthopediatrics-corp/news/orthopediatrics-corp-expands-specialty-bracing-120000742</link>
<guid isPermaLink="true">https://6ix.com/company/orthopediatrics-corp/news/orthopediatrics-corp-expands-specialty-bracing-120000742</guid>
<pubDate>Thu, 13 Nov 2025 12:00:00 GMT</pubDate>
<description>WARSAW, Ind., Nov. 13, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the expansion of its OrthoPediatrics Specialty Bracing (“OPSB”) portfolio with two new products launches, the PediHip™ Rigid Brace and PediHip™ Modular Abduction Systems. The company now has 31 systems within its OPSB division. Developed in collaboration with globally recognized pe</description>
</item>
<item>
<title>OrthoPediatrics to Participate in Upcoming Conferences</title>
<link>https://6ix.com/company/orthopediatrics-corp/news/orthopediatrics-participate-upcoming-conferences-210500396</link>
<guid isPermaLink="true">https://6ix.com/company/orthopediatrics-corp/news/orthopediatrics-participate-upcoming-conferences-210500396</guid>
<pubDate>Tue, 04 Nov 2025 21:05:00 GMT</pubDate>
<description>WARSAW, Ind., Nov. 04, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, a company focused exclusively on advancing the field of pediatric orthopedics, today announced that it will participate in three upcoming investor conferences. Event: Stifel 2025 Healthcare Conference Format: Fireside Chat Date: Thursday, November 13, 2025Time: 1:20 pm ET Event: Jeffries Global He</description>
</item>
<item>
<title>OrthoPediatrics Corp. Reports Third Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/orthopediatrics-corp/news/orthopediatrics-corp-reports-third-quarter-200500124</link>
<guid isPermaLink="true">https://6ix.com/company/orthopediatrics-corp/news/orthopediatrics-corp-reports-third-quarter-200500124</guid>
<pubDate>Tue, 28 Oct 2025 20:05:00 GMT</pubDate>
<description>Increased Third Quarter 2025 Revenue 12% Year-over-year, and Increased Adjusted EBITDA by 56% year-over-yearWARSAW, Ind., Oct. 28, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its financial results for the third quarter ended September 30, 2025. Third Quarter 2025 and Recent Business Highlights Helped over 37,000 children in the third quarter of 20</description>
</item>
<item>
<title>OrthoPediatrics Corp. Receives FDA approval for 3P™ Pediatric Plating Platform™ Small-Mini System, the second of several systems in the 3P family</title>
<link>https://6ix.com/company/orthopediatrics-corp/news/orthopediatrics-corp-receives-fda-approval-200400016</link>
<guid isPermaLink="true">https://6ix.com/company/orthopediatrics-corp/news/orthopediatrics-corp-receives-fda-approval-200400016</guid>
<pubDate>Tue, 28 Oct 2025 20:04:00 GMT</pubDate>
<description>WARSAW, Ind., Oct. 28, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the FDA approval of its 3P™ Pediatric Plating Platform™ Small-Mini System, the second of several systems in the 3P family. This represents the company’s 6th FDA approval in 2025. The 3P Small-Mini System is a versatile plate and screw solution featuring variable-angle locking impla</description>
</item>
<item>
<title>OrthoPediatrics Corp. to Report Third Quarter Financial Results on October 28, 2025</title>
<link>https://6ix.com/company/orthopediatrics-corp/news/orthopediatrics-corp-report-third-quarter-200500551</link>
<guid isPermaLink="true">https://6ix.com/company/orthopediatrics-corp/news/orthopediatrics-corp-report-third-quarter-200500551</guid>
<pubDate>Wed, 15 Oct 2025 20:05:00 GMT</pubDate>
<description>WARSAW, Ind., Oct. 15, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its third quarter 2025 financial results on October 28, 2025 after the market closes. OrthoPediatrics will host a conference call on Tuesday, October 28, 2025 at 4:30 p.m. ET to discuss the results. Investors interested in listening to the c</description>
</item>
<item>
<title>OrthoPediatrics Corp. Announces Preliminary Third Quarter 2025 Revenue and Revised 2025 Guidance</title>
<link>https://6ix.com/company/orthopediatrics-corp/news/orthopediatrics-corp-announces-preliminary-third-200500248</link>
<guid isPermaLink="true">https://6ix.com/company/orthopediatrics-corp/news/orthopediatrics-corp-announces-preliminary-third-200500248</guid>
<pubDate>Thu, 09 Oct 2025 20:05:00 GMT</pubDate>
<description>Company to host conference call today, October 9th, 2025, to discuss the financial results and updated outlookWARSAW, Ind., Oct. 09, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced preliminary unaudited financial highlights for the third quarter ended September 30, 2025, and revised 2025 financial guidance. Preliminary Third Quarter 2025 Results Helpe</description>
</item>
<item>
<title>OrthoPediatrics Corp. Completes First Procedures with VerteGlide™ Spinal Growth Guidance System</title>
<link>https://6ix.com/company/orthopediatrics-corp/news/orthopediatrics-corp-completes-first-procedures-110000048</link>
<guid isPermaLink="true">https://6ix.com/company/orthopediatrics-corp/news/orthopediatrics-corp-completes-first-procedures-110000048</guid>
<pubDate>Wed, 10 Sep 2025 11:00:00 GMT</pubDate>
<description>WARSAW, Ind., Sept. 10, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the completion of the first U.S. surgical procedures with the VerteGlide Spinal Growth Guidance System (“VerteGlide”), used to treat Early Onset Scoliosis (“EOS”). Dr. Richard McCarthy, a pediatric orthopedic spine surgeon in Louisville, Kentucky who, along with Dr. Kent Walker, p</description>
</item>
<item>
<title>OrthoPediatrics Corp. Announces Distribution Agreement with MY01 Inc.</title>
<link>https://6ix.com/company/orthopediatrics-corp/news/orthopediatrics-corp-announces-distribution-agreement-110000336</link>
<guid isPermaLink="true">https://6ix.com/company/orthopediatrics-corp/news/orthopediatrics-corp-announces-distribution-agreement-110000336</guid>
<pubDate>Fri, 05 Sep 2025 11:00:00 GMT</pubDate>
<description>Advancing Care for Pediatric Trauma PatientsWARSAW, Ind., Sept. 05, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics announced today a new distribution partnership with MY01, an innovative medical technology company focused on transforming the diagnosis of limb perfusion injuries. This collaboration will expand access to MY01’s Continuous Perfusion Sensing Technology™ (CPST™) Platform for children and ado</description>
</item>
<item>
<title>OrthoPediatrics Corp. Announces the Appointment of Kelly Fischer to its Board of Directors</title>
<link>https://6ix.com/company/orthopediatrics-corp/news/orthopediatrics-corp-announces-appointment-kelly-200500637</link>
<guid isPermaLink="true">https://6ix.com/company/orthopediatrics-corp/news/orthopediatrics-corp-announces-appointment-kelly-200500637</guid>
<pubDate>Mon, 25 Aug 2025 20:05:00 GMT</pubDate>
<description>WARSAW, Ind., Aug. 25, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the appointment of Kelly Fischer to its Board of Directors effective as of August 8, 2025. The appointment was made concurrent with the announcement of the retirement of Terry Schlotterback from the OrthoPediatrics Board of Directors, effective as of August 8, 2025. “We’re excited</description>
</item>
<item>
<title>OrthoPediatrics Corp. Reports Second Quarter 2025 Financial Results and Increases Full Year 2025 Revenue Guidance</title>
<link>https://6ix.com/company/orthopediatrics-corp/news/orthopediatrics-corp-reports-second-quarter-200500199</link>
<guid isPermaLink="true">https://6ix.com/company/orthopediatrics-corp/news/orthopediatrics-corp-reports-second-quarter-200500199</guid>
<pubDate>Tue, 05 Aug 2025 20:05:00 GMT</pubDate>
<description>Second Quarter 2025 Revenue Surpasses $60 million for the First Time in Company History, and Increased Adjusted EBITDA by 58% year-over-yearWARSAW, Ind., Aug. 05, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its financial results for the second quarter ended June 30, 2025. Second Quarter 2025 and Business Highlights Helped over 37,000 children in t</description>
</item>
<item>
<title>OrthoPediatrics Corp. Announces Continued Expansion of Specialty Bracing Division Into New Territories with Multiple Clinics</title>
<link>https://6ix.com/company/orthopediatrics-corp/news/orthopediatrics-corp-announces-continued-expansion-200100615</link>
<guid isPermaLink="true">https://6ix.com/company/orthopediatrics-corp/news/orthopediatrics-corp-announces-continued-expansion-200100615</guid>
<pubDate>Tue, 05 Aug 2025 20:01:00 GMT</pubDate>
<description>WARSAW, Ind., Aug. 05, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the expansion of its OrthoPediatrics Specialty Bracing (“OPSB”) division with multiple new clinics and entry into two new territories. The expansion of the OPSB division includes rapid expansion of greenfield clinic locations in California, Ohio, and Colorado. Entered a new territo</description>
</item>
<item>
<title>OrthoPediatrics Corp. to Participate in the 45th Canaccord Genuity Annual Growth Conference</title>
<link>https://6ix.com/company/orthopediatrics-corp/news/orthopediatrics-corp-participate-45th-canaccord-200500337</link>
<guid isPermaLink="true">https://6ix.com/company/orthopediatrics-corp/news/orthopediatrics-corp-participate-45th-canaccord-200500337</guid>
<pubDate>Mon, 04 Aug 2025 20:05:00 GMT</pubDate>
<description>WARSAW, Ind., Aug. 04, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey, President & Chief Executive Officer, and Fred Hite, Chief Operating Officer, and Chief Financial Officer, are scheduled to participate in a fireside chat at the 45th Canaccord Genuity Annual Growth Conference, held in Boston, MA. Event: 45th Canaccord Genuity Annu</description>
</item>
<item>
<title>OrthoPediatrics Corp. Launches 3P™ Pediatric Plating Platform™ Hip System and Completes First Case</title>
<link>https://6ix.com/company/orthopediatrics-corp/news/orthopediatrics-corp-launches-3p-pediatric-120500031</link>
<guid isPermaLink="true">https://6ix.com/company/orthopediatrics-corp/news/orthopediatrics-corp-launches-3p-pediatric-120500031</guid>
<pubDate>Fri, 01 Aug 2025 12:05:00 GMT</pubDate>
<description>WARSAW, Ind., Aug. 01, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the US launch and first surgical case of the new 3P™ Pediatric Plating Platform™ Hip System, used to treat proximal femur fractures and deformities. “The 3P Pediatric Plating Platform Hip System is an exceptional product that would not be possible without our remarkable design surg</description>
</item>
<item>
<title>OrthoPediatrics Corp. to Report Second Quarter Financial Results on August 5, 2025</title>
<link>https://6ix.com/company/orthopediatrics-corp/news/orthopediatrics-corp-report-second-quarter-200500444</link>
<guid isPermaLink="true">https://6ix.com/company/orthopediatrics-corp/news/orthopediatrics-corp-report-second-quarter-200500444</guid>
<pubDate>Tue, 22 Jul 2025 20:05:00 GMT</pubDate>
<description>WARSAW, Ind., July 22, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its second quarter 2025 financial results on August 5, 2025 after the market closes. OrthoPediatrics will host a conference call on Tuesday, August 5, 2025 at 4:30 p.m. ET to discuss the results. Investors interested in listening to the conf</description>
</item>
</channel>
</rss>